Jianmin Pharmaceutical Group Co Ltd (600976) — Financial Flexibility Index
Jianmin Pharmaceutical Group Co Ltd (600976) has a Financial Flexibility Index of 0.07x as of December 2025. Free cash flow of CN¥130.05 Million (operating CF CN¥106.82 Million minus capex CN¥23.23 Million) represents 0% of total liabilities (CN¥1.81 Billion). Check strategic asset allocation of Jianmin Pharmaceutical Group Co Ltd to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Jianmin Pharmaceutical Group Co Ltd Financial Flexibility Index (2003–2025)
Historical Financial Flexibility Index trend for Jianmin Pharmaceutical Group Co Ltd across 23 annual periods. See 600976 working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Jianmin Pharmaceutical Group Co Ltd (2003–2025)
Year-by-year free cash flow to debt coverage for Jianmin Pharmaceutical Group Co Ltd. For the full company profile including market capitalisation, see how much is Jianmin Pharmaceutical Group Co Ltd worth.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.21x | CN¥375.20 Million | CN¥274.53 Million | CN¥1.81 Billion | ▲ +7.1% |
| 2024 | 0.19x | CN¥354.55 Million | CN¥234.27 Million | CN¥1.83 Billion | ▲ +11.4% |
| 2023 | 0.17x | CN¥332.89 Million | CN¥268.39 Million | CN¥1.91 Billion | ▼ -3.7% |
| 2022 | 0.18x | CN¥283.83 Million | CN¥215.87 Million | CN¥1.57 Billion | ▼ -27.9% |
| 2021 | 0.25x | CN¥315.17 Million | CN¥259.18 Million | CN¥1.26 Billion | ▲ +60.2% |
| 2020 | 0.16x | CN¥171.12 Million | CN¥125.54 Million | CN¥1.09 Billion | ▼ -21.6% |
| 2019 | 0.20x | CN¥143.76 Million | CN¥74.45 Million | CN¥720.63 Million | ▲ +8.7% |
| 2018 | 0.18x | CN¥105.97 Million | CN¥63.60 Million | CN¥577.11 Million | ▲ +94.4% |
| 2017 | 0.09x | CN¥77.13 Million | CN¥35.20 Million | CN¥816.71 Million | ▼ -48.8% |
| 2016 | 0.18x | CN¥143.26 Million | CN¥113.84 Million | CN¥776.45 Million | ▲ +42.7% |
| 2015 | 0.13x | CN¥78.20 Million | CN¥48.45 Million | CN¥604.72 Million | ▼ -45.8% |
| 2014 | 0.24x | CN¥130.00 Million | CN¥103.23 Million | CN¥544.79 Million | ▲ +74.0% |
| 2013 | 0.14x | CN¥69.26 Million | CN¥45.36 Million | CN¥504.92 Million | ▼ -54.2% |
| 2012 | 0.30x | CN¥107.14 Million | CN¥98.17 Million | CN¥357.90 Million | ▲ +230.0% |
| 2011 | -0.23x | CN¥-67.09 Million | CN¥-75.54 Million | CN¥291.28 Million | ▼ -133.9% |
| 2010 | 0.68x | CN¥155.49 Million | CN¥150.08 Million | CN¥228.78 Million | ▲ +298.3% |
| 2009 | 0.17x | CN¥81.19 Million | CN¥66.69 Million | CN¥475.79 Million | ▼ -42.9% |
| 2008 | 0.30x | CN¥118.79 Million | CN¥110.11 Million | CN¥397.80 Million | ▲ +1313.5% |
| 2007 | 0.02x | CN¥3.02 Million | CN¥-6.88 Million | CN¥143.07 Million | ▼ -91.7% |
| 2006 | 0.26x | CN¥72.79 Million | CN¥56.18 Million | CN¥285.18 Million | ▲ +577.2% |
| 2005 | -0.05x | CN¥-16.12 Million | CN¥-34.63 Million | CN¥301.33 Million | ▼ -119.0% |
| 2004 | 0.28x | CN¥61.78 Million | CN¥4.13 Million | CN¥219.38 Million | ▼ -33.2% |
| 2003 | 0.42x | CN¥102.07 Million | CN¥4.19 Million | CN¥242.31 Million | — |